tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
Comparison · Analytics
DoseFinding vs Tplyr
A side-by-side editorial comparison of DoseFinding and Tplyr — release velocity, themes, recent moves, and the top alternatives to consider.
Shared themes:clinical-trials
DoseFinding vs Tplyr: at a glance
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
What is Tplyr?
Tplyr made clinical summary tables explain where every number came from.
Tplyr builds clinical summary tables through a layered grammar — count, descriptive statistics, and shift layers assembled onto a table object. The 1.0.0 release added a traceability metadata framework that lets a user ask which source rows produced any given cell, and later releases extended it to cases the first pass missed. The package is maintained by Atorus within the pharmaverse ecosystem.
DoseFinding vs Tplyr: editorial side-by-side
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Tplyr
0.0ANALYTICS
Tplyr made clinical summary tables explain where every number came from.
◆ Current state
Tplyr builds clinical summary tables through a layered grammar — count, descriptive statistics, and shift layers assembled onto a table object. The 1.0.0 release added a traceability metadata framework that lets a user ask which source rows produced any given cell, and later releases extended it to cases the first pass missed. The package is maintained by Atorus within the pharmaverse ecosystem.
◆ Where it's heading
Post-1.0 work has been about completing the metadata story and filling gaps in layer composition rather than adding table types — metadata for missing subjects, add_anti_join(), missing-subject rows, data limiting, and fixes to nested count layers where an inner value appears under several outer groups. Releases cluster tightly after a major version, then go quiet, and the window ends with a patch issued days after the release it corrects.
◆ Prediction
Further releases will most likely continue closing traceability and nested-layer edge cases rather than introducing new layer types, following the pattern of both post-1.0 feature releases.
Alternatives to DoseFinding and Tplyr
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or Tplyr.
rlistings
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
hoardr
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
riem
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
datasetjson
datasetjson rebuilt its object model to track the CDISC Dataset-JSON 1.1 schema.
See all DoseFinding alternatives → · See all Tplyr alternatives →
Recent activity from DoseFinding and Tplyr
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoTplyrMissing-subject metadata, add_anti_join(), and nested-layer fixes
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
- 3y agoTplyrMetadata vignette fix and parenthesis hugging
- 3y agoTplyrDenominator logic fix ahead of CRAN release
- 3y agoTplyrReverse-dependency fix
- 3y agoTplyr1.0.0 introduces the traceability metadata framework ⚡
Frequently asked questions
What is the difference between DoseFinding and Tplyr?
Both compete on the same themes — clinical-trials — within Analytics. DoseFinding and Tplyr are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is DoseFinding better than Tplyr?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and Tplyr are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
What are the best alternatives to Tplyr?
Top Tplyr alternatives in Analytics are ranked by recent ship velocity. Browse the "Tplyr alternatives" section above for the current picks, or visit /alternatives/tplyr for the full list with editorial commentary on each.